ÀÌ°©¼®(Li Kap-Sok) - Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ÇǺΰúÇб³½Ç
Abstract
For allergists, itch is the most important symptom of atopic dermatitis (AD), and at the same time, the most difficult-to-manage complaint of atopic patient. Rather than just one symptom of AD, itch has more profound clinical significance in the following sense: itch, as a key component of so-called ¡¯itch-scratch¡¯ vicious-cycle, plays a central role in the development and persistence of AD, thus, treating itch is not just alleviating one symptom of AD, but stopping genesis and progress of AD. In other words, itch is AD in itself. Pathomechanism underlying development of itch in AD could be summarized as follows: First, exogenous triggering factors penetrate impaired barrier, leading to allergic skin inflammation. Resulting characteristic itch of AD is amplified through the ¡¯itch ¡æ scratch ¡æ inflammation ¡æ (again) ¡æ itch ¡æ...¡¯ vicious-cycle. Thus, pathomechanism-based management strategy could be provided accordingly-avoidance of triggering factor, repair of impaired barrier, control of skin inflammation, and decreasing desire for itch/scratch. Among them, controlling inflammation is thought to be most effective measure based on the clinical experiences, for skin inflammation, as one of key components in ¡¯itch-scratch-inflammation¡¯ vicious-cycle, at the same time, is a crucial connecting link between OUTSIDE and INSIDE. However, individualized approach should be taken for patient per se. Finally, following topics may be future topics for doctors always hungry for new weapon against AD and patients suffering from this out-of-place (a-top-y) disease: central itch pathway-emerging new hero; neural sensitization - still in the Dark-Ages in terms of diagnosis and management; and scratch-just in its infancy.
Å°¿öµå
Atopic dermatitis, Itch, Pathogenesis, Treatment
KMID :
1035620140020010008
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)